...
10 Stacks Research

Research use
only.

Our products are intended exclusively for laboratory research applications. Please confirm before entering.

By entering, you agree to our Terms and acknowledge our research-use-only policy.

Free Shipping on Orders Over $150 · Stack and Save 25%

GHK-Cu: 50 Years of Research

What the published literature on the copper tripeptide actually shows, and where it stops.

In 1973, Loren Pickart was studying how human blood serum affected liver tissue kept alive in culture. Serum from donors in their twenties behaved differently from serum from donors in their sixties. Old tissue bathed in young serum started synthesizing protein the way young tissue did.

Pickart went looking for what in the serum was responsible. He found a fragment of three amino acids carried on albumin: glycine, histidine, lysine. GHK.

Fifty years later it is one of the most heavily studied small peptides in human biology, and one of the most heavily oversold. This is what the literature contains.

The copper part

GHK on its own is modestly active. Bound to copper it becomes GHK-Cu, and the binding is unusually tight. The log stability constant for the GHK copper complex is 16.44. The dipeptide GH binds copper at 8.68. That is a difference of roughly eight orders of magnitude. The literature treats GHK as a copper transport molecule (Lau and Sarkar, Biochemical Journal, 1981).

Copper is a required cofactor for lysyl oxidase, superoxide dismutase and several other enzymes. Loose copper in tissue also drives oxidative damage. A molecule that holds copper tightly and releases it under control is doing something a copper salt cannot. Most research on GHK-Cu treats the peptide and the metal as a single unit.

What it does to the extracellular matrix

The best-replicated finding in the GHK literature is that it changes how fibroblasts build and maintain connective tissue.

Maquart and colleagues showed in 1988 that GHK-Cu at picomolar to nanomolar concentrations stimulated collagen synthesis in skin fibroblasts and increased total protein, glycosaminoglycan and DNA accumulation in rat dermal wounds. Later work added decorin, a small proteoglycan that governs how collagen fibrils assemble.

There is a finding that travels alongside that one and rarely shows up in vendor summaries. Simeon and colleagues reported in 2000 that GHK-Cu also raises expression of matrix metalloproteinases and their inhibitors. It increases both the construction and the breakdown of the matrix. Those authors said the compound should be handled with caution for exactly that reason.

Wound healing models

Animal wound work is where GHK-Cu has its most consistent record.

In rabbit models, topical GHK-Cu improved wound contraction and sped granulation tissue formation. In a 2003 rat study of ischemic open wounds, thirteen days of topical treatment reduced wound size by 64.5 percent in the GHK-Cu group, against 45.6 percent for vehicle and 28.2 percent for untreated controls (Canapp et al., Veterinary Surgery, 2003).

Separate work found GHK increased nerve growth factor production along with neurotrophins NT-3 and NT-4, and supported nerve fiber regeneration and Schwann cell proliferation in collagen tubes.

All of that is animal and cell culture data.

The gene expression turn

The GHK literature changed direction in 2012, and it happened by accident.

A team working across Boston University and the Broad Institute was studying emphysema. They profiled lung tissue from six COPD transplant patients and two donor lungs, sampling from the apex to the base of each lung, and matched gene expression against emphysema severity measured by micro-CT imaging. They found 127 genes whose expression tracked with how destroyed the tissue was.

Then they took that signature to the Connectivity Map, a database that matches gene expression patterns against the patterns thousands of compounds produce, and asked what would reverse it. GHK came back.

So they tested it. GHK treatment of human lung fibroblasts reproduced TGF-beta induced gene patterns, organized the actin cytoskeleton, raised integrin beta-1 expression, and restored collagen contraction in fibroblasts taken from COPD lungs (Campbell et al., Genome Medicine, 2012).

GHK surfaced from a database query. Nobody in that lab had set out to study copper peptides.

That result prompted a broader look at what GHK does transcriptionally. Pickart and Margolina reported that across roughly 13,400 genes assayed, GHK shifted expression by 50 percent or more in 4,192 of them, about 31 percent of the genes tested, raising expression in 59 percent of those and lowering it in 41 percent.

That number gets quoted constantly. It is worth being clear on what it means. Broad transcriptional activity in a cell culture assay tells you a compound is biologically busy. It does not tell you the direction of that activity is useful in a living organism. The authors of the gene profiling work said as much, noting that compounds screened this way often lack the supporting biological data to interpret the result.

The age curve

Plasma GHK measures around 200 ng/mL at age 20. By age 60 it is closer to 80 ng/mL.

This single fact is what the entire consumer copper peptide market is built on. The measurement is real. The inference people draw from it, that restoring the level restores the function, has not been tested in humans.

Where the research stops

The gaps are specific.

  • There are no completed human clinical trials for most GHK-Cu applications. The 2018 review that produced the widely quoted gene numbers says so plainly and calls for clinical studies to be run.
  • Human cosmetic studies of topical copper peptides do exist. A 2024 review found them small in sample size and short in duration, and concluded that firmer conclusions require further work.
  • Hair is the weakest area by a distance. The follicle study most often cited in copper peptide hair marketing, published in 2007, tested AHK-Cu, a different copper peptide. GHK-Cu hair claims rest on much thinner ground than the skin and wound literature does.
  • Nearly everything above is cell culture and rodent work. The distance between a rodent wound model and a human outcome is where most promising compounds fail.

Why we carry it

GHK-Cu has a fifty year published record and a discovery pathway that ran through an unbiased database query. In a category where most compounds have a handful of papers behind them, that is rare.

It is still a research compound. Our GHK-Cu is sold for laboratory research use only. The Certificate of Analysis for the current batch is linked on the product page.

Sources

  1. Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biology. 1973;243(124):85-87.
  2. Lau SJ, Sarkar B. Biochemical Journal. 1981. (Copper binding constants for GHK.)
  3. Maquart FX, et al. FEBS Letters. 1988. (Collagen synthesis in fibroblast culture.)
  4. Simeon A, et al. Journal of Investigative Dermatology. 2000. (Matrix metalloproteinase expression.)
  5. Canapp SO Jr, et al. Veterinary Surgery. 2003. (Topical GHK-Cu in ischemic open wounds.)
  6. Campbell JD, McDonough JE, Zeskind JE, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Medicine. 2012;4:67. https://genomemedicine.biomedcentral.com/articles/10.1186/gm367
  7. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. https://www.mdpi.com/1422-0067/19/7/1987
  8. Pickart L, Margolina A. Skin Regenerative and Anti-Cancer Actions of Copper Peptides. Cosmetics. 2018;5(2):29. https://www.mdpi.com/2079-9284/5/2/29

Products sold by 10 Stacks Research are intended exclusively for laboratory research. They are not drugs, foods or cosmetics, and they are not for human or veterinary use. 10 Stacks Research is not a pharmacy and does not provide medical advice.

Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.